Ronald Blue Trust, Inc. Meridian Bioscience Inc Transaction History

Ronald Blue Trust, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$0.0 - $33.97 $0 - $2,649	-78 Reduced 4.98%	1,487 $49,000
Q4 2022 Jan 17, 2023	BUY	$31.15 - $33.39 $29,094 - $31,186	934 Added 148.02%	1,565 $49,000
Q3 2022 Oct 21, 2022	BUY	$30.9 - $33.55 $3,337 - $3,623	108 Added 20.65%	631 $19,000
Q2 2022 Aug 09, 2022	BUY	$23.75 - $31.69 $12,421 - $16,573	523 New	523 $14,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.